Global Funding For Nanotechnology Amounts To Over $25 Billion In 2008

Research and Markets has announced the addition of the "The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition" report to their offering.

The Nanotechnology Opportunity Report (NOR) 2008, 3rd Edition provides the most comprehensive report on the economic impact of nanotechnologies the author has released to date. The report contains over 1,000 pages, several thousand figures and tables, and offers full market forecasts for the key industrial sectors impacted by nanotech, including:

  • Electronics & Semiconductors
  • Textiles
  • Energy
  • Food
  • Drug Delivery
  • Chemicals & Advanced Materials
  • Printing & Packaging
  • Automotive
  • Aerospace & Defense
  • Medical Devices & Therapeutics
  • Medical Diagnostics

The first edition of The Nanotechnology Opportunity Report in 2002 was described by NASA as “a breakthrough… the first complete report of the state of our field” and the new edition is the first complete picture of the economic impact of nanotechnologies.

Following ten years and billions of dollars of government funding the report charts the influence of nanotechnologies in shifting from merely observing nature to choreographing it.

Designed for corporate strategists and policy advisors, The Nanotechnology Opportunity Report 2008 looks at the current and future impact of nanotech based on sound and tested economic models based on technology diffusion, returns on government funded R&D and corporate R&D in over a thousand companies worldwide.

Our CEO explained, “In 2002 we predicted that there would be no nanotechnology industry and the recent failed IPOs and collapse of ‘pure play nanotech’ companies has shown the value of our rational approach to nanotechnologies. In the past seven years almost a billion dollars of venture capital money has been poured down the drain as a result of not understanding the crucial difference between a science project and a successful company. However there are increasing numbers of companies generating solid revenues from nanotechnologies.”

Value Of Nano-Enabled Products Reaches $166.6 Billion In 2008; Global Funding For Nanotechnology In 2008 Amounts To Over $25 Billion With A Billion Dollars Of Venture Capital Generating Scant Return

The author releases the Nanotechnology Opportunity Report™ (NOR), 3rd Edition, “the defining report in the field of nanotechnology” according to NASA.

While some lament the lack of nanotech IPOs, nanoscience has evolved over the last seven years since the first Nanotechnology Opportunity Report™ into a stable technology platform enabling a new range of higher value products.

This new edition of the NOR distils everything that the author has learned over the past ten years into one document. It highlights the companies and technologies making real returns on investment and questions whether VCs can invest in emerging technology in the 21st Century without rethinking their 20th Century business models.

CEO, Tim Harper explained, “In 2001 we predicted that there would not be a ‘nanotechnology industry’ and the recent slew of failed IPOs and collapse of ‘pure play nanotech’ companies has validated the value of the author’s rational approach. Almost a billion dollars of investors cash has been poured down the drain by investors who did not understand the crucial difference between a science project and a successful company, egged on by a plethora of nanotech ‘experts,’ while large corporations have laughed all the way to the bank.”

The new 1000-page Nanotechnology Opportunity Report, 3rd Edition, provides:

  • New Content: Analysis and comprehensive reports on key market sectors including electronics, drug delivery, food, textiles and energy.
  • New Data: on government funding, market sizes and rates of growth for key market sectors
  • New Economic Model: The author’s model includes global and corporate R&D nanotech spending for thousands of companies, and provides growth predictions and nanotechnology penetration rates.

Key Findings:

  • After ten years of R&D, maturing supply chains and quality control of nanomaterials is finally enabling higher value-added uptake.
  • Most nanomaterials have been commoditized by existing industry players cutting start ups out of the game.
  • The market for products enabled by nanotechnologies will reach US$ 263 billion by 2012.
  • The highest growth rates will be in the convergence between bio- and nanotechnologies in the healthcare and pharmaceutical sectors.

Highlights:

  • Company Profiles: Hundreds of company profiles from key market sectors
  • Key Market Sector Analysis including market sizes, future growth rates, key companies, applicable nanotechnologies and their applications
  • Cost and Benefit Analysis Tables for nanotechnologies’ application to market sector products
  • Timeline Roadmaps for nanotechnologies’ application to market sector products
  • Government Funding for nearly 40 countries, including methods of distribution, timescales for funding, and areas of focus.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Research and Markets. (2019, February 15). Global Funding For Nanotechnology Amounts To Over $25 Billion In 2008. AZoNano. Retrieved on April 16, 2024 from https://www.azonano.com/news.aspx?newsID=6688.

  • MLA

    Research and Markets. "Global Funding For Nanotechnology Amounts To Over $25 Billion In 2008". AZoNano. 16 April 2024. <https://www.azonano.com/news.aspx?newsID=6688>.

  • Chicago

    Research and Markets. "Global Funding For Nanotechnology Amounts To Over $25 Billion In 2008". AZoNano. https://www.azonano.com/news.aspx?newsID=6688. (accessed April 16, 2024).

  • Harvard

    Research and Markets. 2019. Global Funding For Nanotechnology Amounts To Over $25 Billion In 2008. AZoNano, viewed 16 April 2024, https://www.azonano.com/news.aspx?newsID=6688.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.